PO27 | B-cell lymphoproliferative disorder and acquired coagulopathy: an insidious link
Background: Acquired coagulation factor inhibitors are autoantibodies that may develop in individuals with autoimmune or neoplastic disorders and should be assessed in patients without personal or familiar history of bleeding disorders. These inhibitors most commonly target factor VIII (FVIII) or v...
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
PAGEPress Publications
2025-08-01
|
| Series: | Bleeding, Thrombosis and Vascular Biology |
| Subjects: | |
| Online Access: | https://www.btvb.org/btvb/article/view/288 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PO21 | Exploring endothelial damage: the interplay between coagulopathy, capillary leak and vasoplegia in sepsis
Published: (2025-08-01) -
PO44 | Emicizumab in acquired haemophilia A
Published: (2025-08-01) -
PO60 | Asymptomatic PNH clone in acquired aplasia (AA)
Published: (2025-08-01) -
PO65 | Utilization of emicizumab in acquired hemophilia A: a case report
Published: (2025-08-01) -
PO90 | Acquired hemophilia A with high-titer inhibitor in a patient with cardiovascular and metabolic comorbidities
Published: (2025-08-01)